India, emerging markets power business of pharma majors amid US slowdown
· thehindubusinessline.com
An analysis of Q1 results show Sun Pharma and Aurobindo Pharma delivering strong growth, while Dr Reddy’s earnings were hit by lower lenalidomide sales and a semaglutide-related provision
Domestic branded formulations, innovative medicines and emerging markets are increasingly cushioning major Indian drugmakers against volatility and pricing pres...